MedPath

Treatment with metformin to reduce insulin requirements in Diabetes in Pregnancy

Not Applicable
Conditions
Gestational diabetes mellitus
Registration Number
SLCTR/2011/009
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Pregnant mothers who are diagnosed to be having GDM after 20 weeks needing additional treatment other than diet and exercise are recruited in to the study

Exclusion Criteria

Those women with GDM before 20 weeks, Those with evidence of IUGR or hypertensive disease at the time of recruitment, Multiple pregnancies, Those who refuse consent for the study, Patients with elevated liver and renal function tests, will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The reduction in insulin requirement per patient [At the end of the study]<br>
Secondary Outcome Measures
NameTimeMethod
Cost reduction in treatment in GDM [At the end of the study]<br>
© Copyright 2025. All Rights Reserved by MedPath